Seerpharma.com.au :: Pharmaceutical Consulting & Training :: Validation, GMP & Compliance UK | Singapore | Korea

   

 

 

Myocardial Infarction: Cause

Description: Prolonged ischemic conditions (a decrease in blood supply to an organ) can lead to the death, or necrosis, of the affected tissue. When this occurs in the heart, it is called myocardial infarction, or heart attack. Whereas angina is a result of a reduced blood flow to the heart muscle, myocardial infarction occurs as a result of a sudden and complete interruption of blood supply to a portion of the heart. This course describes the cellular and molecular processes that lead to angina and myocardial infarct.

COURSE OUTLINE
INTRODUCTION
1. Course Information
2. Interface Tour
3. Course Overview

PATHOPHYSIOLOGY
4. Objectives
5. Pathophysiology
6. Arterial Clotting
7. Coagulation Cascade
8. Risk Factors
9. Progress Check

EPIDEMIOLOGY
10. Objectives
11. Incidence and Demographics
12. Progress Check

CONCLUSION
13. Summary


COURSE OBJECTIVES
Students completing this course should be able to:
  • Describe the steps of atherosclerotic plaque formation
  • Understand how plaque formation leads to angina
  • Describe the role of platelets and the coagulation cascade in myocardial infarction
  • List 5 risk factors associated with coronary heart disease
  • Understand the social and economic costs of coronary heart disease

 

   

SeerPharma has partnered with GeneEd to now distribute courses in Major Therapeutic Areas, Clinical Research, and Biotechnology & Genetics.

© SeerPharma Pty Ltd 2008 | Resources | Privacy Policy